Screening method of leukoencephalopathy genes
A leukoencephalopathy and genetic technology, applied in the direction of biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of difficult diagnosis, complex clinical manifestations of leukoencephalopathy, etc., achieve high accuracy, small individual damage, predict good sex effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0039] A screening method for leukoencephalopathy gene of the present invention comprises the following steps:
[0040] 1. Sample library preparation:
[0041] 1.1) Ultrasound fragmentation: the initial amount is 3 μg, diluted to 30 ng / μL with 1×low TE Buffer. Covaris S2 ultrasonic instrument was used for ultrasonic fragmentation, and the values of Covaris system were set according to the standard, 6 cycles×60s, water bath temperature: 5°C, duty cycle: 20%, intensity: 5, mode: Frequency sweeping.
[0042]1.2) End filling: Take 100 μL fragmented DNA, 8 μL dNTPs, 2 μL End Polishing enzyme I (10 U / μL, Agilent), 16 μL End Polishing enzyme II (5 U / μL, Agilent), and add water to a total volume of 200 μL. Incubate at 25°C for 30min. DNA was purified using PureLink PCR purification kit (Invitrogen).
[0043] 1.3) Ligate P1 and P2 adapters: 26 μL each of SOLiD adapter 1 (PleA) 50 μmol / L and adapter 2 (P2eA) 50 μmol / L (Applied Biosystems), 48 μL of end-filled DNA, 10 μL of T4 DNA l...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com